Showing results (2141-2150 of 2,319) with videos related to

Sort By:
Pageof 232
Journal of the American Academy of Child and Adolescent Psychiatry|August 25, 2015
Web Intervention for Adolescents Affected by Disaster: Population-Based Randomized Controlled TrialKenneth J Ruggiero, Matthew Price, Zachary Adams, et al.
Gynecologic Oncology|January 29, 2023
Results of TRIO-15, a multicenter, open-label, phase II study of the efficacy and safety of ganitumab in patients with recurrent platinum-sensitive ovarian cancerT M Davidson, C L Lebreton, A E Wahner Hendricksen, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 13, 2026
Clinically reported covert cerebrovascular disease and risk of neurological disease: a whole-population cohort of 367 988 people using natural language processingMatthew Henry Iveson, Mome Mukherjee, Emma M Davidson, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|July 4, 2025
Virtual humans in geriatric care: an integrative reviewMichael Joseph S Dino, Kenneth W Dion, Peter M Abadir, et al.
Plos One|December 20, 2021
Healthcare-associated links in transmission of nontuberculous mycobacteria among people with cystic fibrosis (HALT NTM) study: Rationale and study designJane E Gross, Silvia Caceres, Katie Poch, et al.
Nursing Reports (Pavia, Italy)|February 25, 2025
Community-Dwelling Filipino Older Adults' Experiences with Virtual Coach for Health-Enhancing Physical Activity (HEPA): A PhenomenologyMichael Joseph S Dino, Kenneth W Dion, Peter M Abadir, et al.
Journal of Environmental Monitoring : JEM|November 1, 2006
Variability in concentrations of potentially toxic elements in urban parks from six European citiesL Madrid, E Diaz-Barrientos, E Ruiz-Cortés, et al.
Plos One|December 20, 2023
Prospective healthcare-associated links in transmission of nontuberculous mycobacteria among people with cystic fibrosis (pHALT NTM) study: Rationale and study designJane E Gross, Silvia Caceres, Katie Poch, et al.
ACS Infectious Diseases|September 15, 2016
Diphenylether-Modified 1,2-Diamines with Improved Drug Properties for Development against Mycobacterium tuberculosisMarie H Foss, Sovitj Pou, Patrick M Davidson, et al.
Signal Transduction and Targeted Therapy|April 17, 2020
SIRT3-mediated inhibition of FOS through histone H3 deacetylation prevents cardiac fibrosis and inflammationXavier Palomer, M Silvia Román-Azcona, Javier Pizarro-Delgado, et al.
Pageof 232